VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $9,615,000 | +20.8% | 73,283 | +16.1% | 0.09% | +20.8% |
| Q2 2014 | $7,962,000 | +9.0% | 63,133 | +13.9% | 0.08% | +5.5% |
| Q1 2014 | $7,306,000 | -11.0% | 55,420 | -20.7% | 0.07% | -6.4% |
| Q4 2013 | $8,206,000 | +12.5% | 69,900 | 0.0% | 0.08% | -2.5% |
| Q3 2013 | $7,293,000 | +21.2% | 69,900 | 0.0% | 0.08% | +8.1% |
| Q2 2013 | $6,017,000 | – | 69,900 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |